AIMN, ITANET, SIE joint position paper for the recognition, prevention and management of NET carcinoid syndrome and crises during peptide receptor radionuclide therapy
European Journal of Nuclear Medicine and Molecular Imaging · 2026
DOI: 10.1007/s00259-025-07596-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Riccardo Laudicella und 21 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, Messina, Italy. Hauptthemen laut MEDLINE: Receptors, Peptide, Neuroendocrine Tumors, Malignant Carcinoid Syndrome. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero della Salute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nuclear Medicine, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, Messina, Italy.
- Unit of Endocrinology, Department of Clinical and Molecular Medicine, Sant 'Andrea University Hospital, ENETS Center of Excellence, Sapienza University of Rome, Rome, Italy.
- Department of Nuclear Medicine, Ordine Mauriziano Hospital, Turin, Italy.
- Nuclear Medicine Unit, Azienda Unità Sanitaria Locale-IRCCS Di Reggio Emilia, Viale Risorgimento, 80, 42123, Reggio Emilia, Italy. rexhep.durmo@ausl.re.it.
- ICU Department of General and Specialist Surgery, Azienda Unità Sanitaria Locale - IRCCS Di Reggio Emilia, Reggio Emilia, Italy.
- Endocrinology, Diabetology and Andrology Unit, Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy.
ORCID-Profile: Rexhep Durmo
Förderung
- Ministero della Salute
Zitieren
APA
Laudicella, R., Faggiano, A., Pirro, V., Durmo, R., Salsi, P., Modica, R., Urso, L., Grana, C. M., Sances, D., Rinzivillo, M., Albertelli, M., Spada, F., Partelli, S., Ferraù, F., Fazio, N., Tafuto, S., Maccauro, M., Bartolomei, M., Panzuto, F., …, & Filice, A. (2026). AIMN, ITANET, SIE joint position paper for the recognition, prevention and management of NET carcinoid syndrome and crises during peptide receptor radionuclide therapy. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-025-07596-2
Vancouver
Laudicella R, Faggiano A, Pirro V, Durmo R, Salsi P, Modica R, et al. AIMN, ITANET, SIE joint position paper for the recognition, prevention and management of NET carcinoid syndrome and crises during peptide receptor radionuclide therapy. European Journal of Nuclear Medicine and Molecular Imaging. 2026. doi:10.1007/s00259-025-07596-2
BibTeX
@article{Laudicella2026,
author = {Laudicella, Riccardo and Faggiano, Antongiulio and Pirro, Valeria and Durmo, Rexhep and Salsi, Pierpaolo and Modica, Roberta and Urso, Luca and Grana, Chiara Maria and Sances, Daniele and Rinzivillo, Maria and Albertelli, Manuela and Spada, Francesca and Partelli, Stefano and Ferraù, Francesco and Fazio, Nicola and Tafuto, Salvatore and Maccauro, Marco and Bartolomei, Mirco and Panzuto, Francesco and De Rimini, Maria Luisa and Lastoria, Secondo and Filice, Angelina},
title = {AIMN, ITANET, SIE joint position paper for the recognition, prevention and management of NET carcinoid syndrome and crises during peptide receptor radionuclide therapy},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
doi = {10.1007/s00259-025-07596-2}
}
EUVIMED